JAVMA news
Board debates policy points on medicinal products
Thorny issues surrounding the appropriate use of medicinal products—and how to handle adverse events—prompted discussion during the Executive Board…
JAVMA news
FDA warns that compounding clenbuterol is illegal
In recent years, the availability of illegal clenbuterol formulations, produced as "compounded" drug product, has
JAVMA news
Horse deaths associated with unapproved drug
An unapproved clenbuterol product associated with two horse deaths in Louisiana has prompted the FDA to remind veterinarians and horse
JAVMA news
Topical gels: An option for panicky pill takers?
There are over 100 drugs advertised as products that can be administered topically to veterinary patients
JAVMA news
Reminder: ECP not approved for use in animals
The Food and Drug Administration's Center for Veterinary Medicine has received reports that certain pharmacies and veterinarians have compounded…
JAVMA news
FDA to enhance pharmaceutical good manufacturing practices
The Food and Drug Administration announced an initiative to enhance the regulation of pharmaceutical manufacturing
JAVMA news
The truth about serum
The anesthesia team is transfusing the patient with plasma believed to contain normal to high protein concentrations.
JAVMA news
Nitrofuran ban in effect
The AVMA reminds veterinarians that the Food and Drug Administration has prohibited all uses of nitrofuran drugs
JAVMA news
Monograph on macrocyclic lactones released
The U.S. Pharmacopeia has released a free monograph on macrocyclic lactones.
JAVMA news
Internet pharmacies and compounding are high-priority areas, FDA says
Posted on March 1, 2002 Since prior coverage on the issue of Internet pharmacies (see JAVMA, June 1, 2001, and Aug. 15, 2001), the AVMA continues…
JAVMA news
Final guidance on anthelmintics use available
The Food and Drug Administration has issued three final guidance documents regarding the use of anthelmintics
JAVMA news
Buprenorphine rescheduled under stricter regulatory control
The Drug Enforcement Administration has rescheduled buprenorphine from a schedule V narcotic to a schedule III narcotic
JAVMA news
FDA seeks comment on Animal Drug User Fee Act
The Food and Drug Administration is seeking comment on the Animal Drug User Fee Act regarding the program's performance and reauthorization.
JAVMA news
AABP embraces disabled livestock, dairy cattle welfare guidelines -
The AABP board of directors endorsed the position on disabled livestock
JAVMA news
FDA to allow more drugs for nonfood minor species
The Food and Drug Administration is proposing regulations to implement the index of Legally Marketed Unapproved New Animal Drugs for Minor Species"…
JAVMA news
Bringing more bovine practitioners into the fold
Reviving the romance of rural practice may be as vital to jump-starting interest in bovine practice as revisiting admissions policies, career…
JAVMA news
Air, water, land, light: all affect cattle - December 15, 2002
Environment was a prominent program theme at the 2002 AABP conference in September in Madison, Wis.
JAVMA news
AVMA Answers: Texas drug compounding case
Given the recent Texas court decision on drug compounding, have the rules on drug compounding changed?
JAVMA news
Bayer seeks veterinary, industry backing before Baytril hearing
Posted on May 1, 2002 The Bayer Corporation is enlisting the veterinary community and food animal industry to help ensure that scientific evidence…
JAVMA news
Harvard study finds BSE poses little threat to U.S. consumers, agriculture
The United States is highly resistant to the introduction of bovine spongiform encephalopathy.
JAVMA news
Stretch your bovine practice potential
Deborah Stevenson, a registered technician who works with Dr. Mark Hilton at Purdue, places a growth implant.
JAVMA news
Bovine practitioners gather in dairyland
The meeting in America's Dairyland teamed sessions on dairy, cow-calf, feedlot, and general cattle topics.